Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

SARS-CoV-2 is a newly emergent coronavirus, which has adversely impacted human health and has led to the COVID-19 pandemic. There is an unmet need to develop therapies against SARS-CoV-2 due to its severity and lack of treatment options. A promising approach to combat COVID-19 is through the neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jianbo, Huang, Betty, Wang, Bo, Titong, Allison, Gallolu Kankanamalage, Sachith, Jia, Zhejun, Wright, Meredith, Parthasarathy, Pannaga, Liu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576208/
https://www.ncbi.nlm.nih.gov/pubmed/33082473
http://dx.doi.org/10.1038/s41598-020-74761-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576208/
https://www.ncbi.nlm.nih.gov/pubmed/33082473
http://dx.doi.org/10.1038/s41598-020-74761-y

Ejemplares similares